Predicting the outcomes of combination therapy in patients with chronic hepatitis C using artificial neural network.
Forough Sargolzaee Aval
Mohamad Reza Raoufy
Seyed Moayed Alavian
MetadataShow full item record
Treatment with Peginterferon Alpha-2b plus Ribavirin is the current standard therapy for chronic hepatitis C (CHC). However, many host related and viral parameters are associated with different outcomes of combination therapy.